Synthesis and Structure−Activity Relationships of cis-Tetrahydrophthalazinone/Pyridazinone Hybrids: A Novel Series of Potent Dual PDE3/PDE4 Inhibitory Agents-Reference-Cited by-同舟云学术

Synthesis and Structure−Activity Relationships of cis-Tetrahydrophthalazinone/Pyridazinone Hybrids: A Novel Series of Potent Dual PDE3/PDE4 Inhibitory Agents

Published:2003-04-12 Issue:10 Volume:46 Page:2008-2016
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Van der Mey Margaretha¹,Bommelé Kirsten M.¹,Boss Hildegard¹,Hatzelmann Armin¹,Van Slingerland Mike¹,Sterk Geert J.¹,Timmerman Hendrik¹

Affiliation:

1. Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, Department of Pharmacochemistry, Vrije Universiteit, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands, Byk Nederland, Zwanenburg, The Netherlands, and Byk Gulden, Konstanz, Germany

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm030776l

Reference34 articles.

1. Investigation into the role of phosphodiesterase IV in bronchorelaxation, including studies with human bronchus

2. Role of protein kinase A in the regulation of cytosolic free calcium in human osteoblast-like SaOS-2 cells

3. Prospects for selective cyclic nucleotide phosphodiesterase inhibitors in the treatment of bronchial asthma

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pyridazinone-based derivatives as anticancer agents endowed with anti-microbial activity: molecular design, synthesis, and biological investigation;RSC Medicinal Chemistry;2024

2. Synthesis of Heterocycles from 2‐Acylbenzoic Acids;European Journal of Organic Chemistry;2023-06-20

3. Solvent‐ and Catalyst‐Free Organic Transformation;Solvent‐Free Methods in Nanocatalysis;2023-01-13

4. Catalyst-Free Green Synthesis of Phthalazinones at Room Temperature;HETEROCYCLES;2023

5. Pharmacophore Modelling and Virtual Screening Studies for the Discovery of Natural Product-based PDE 3/4 Dual Inhibitors for COPD;Letters in Drug Design & Discovery;2022-10